AR041885A1 - Compuesto de sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion - Google Patents

Compuesto de sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion

Info

Publication number
AR041885A1
AR041885A1 ARP030104038A ARP030104038A AR041885A1 AR 041885 A1 AR041885 A1 AR 041885A1 AR P030104038 A ARP030104038 A AR P030104038A AR P030104038 A ARP030104038 A AR P030104038A AR 041885 A1 AR041885 A1 AR 041885A1
Authority
AR
Argentina
Prior art keywords
alkyl
hydrogen
composition
pharmaceutical composition
sulfonamide
Prior art date
Application number
ARP030104038A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR041885A1 publication Critical patent/AR041885A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un compuesto de sulfonamida que tiene la fórmula (1), en la cual: Ar es fenilo sustituido o sin sustituir con uno o dos de los siguientes: halógenos, CN, S(alquilo C1-6), CF3, OCF3, SCF3, alquilo C1-6, alcoxi C1-6, CO2(alquilo C1-6) o NO2; Y es O o S; Z es hidrógeno, halógeno o alquilo C1-6; R2 es hidrógeno, halógeno, CN o alquilo C1-4; R1 es hidrógeno o alquilo C1-6; o una sal farmacéuticamente aceptable del mismo. Composición farmacéutica que comprende un compuesto de fórmula (1) y un vehículo o excipiente farmacéuticamente aceptable. La presente se refiere a sulfonamidas, composiciones farmacéuticas que las contienen y su uso para tratar estados asociados con un desequilibrio de urotensina-II antagonizando el receptor de uretensina-II. Dichos estados pueden ser fallo cardiaco congestivo, apoplejía, enfermedad cardiaca isquémica, angina, isquemia de miocardio, arritmia cardiaca, hipertensión esencial y pulmonar, enfermedad renal, fallo renal agudo y crónico, entre otros.
ARP030104038A 2002-11-06 2003-11-04 Compuesto de sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion AR041885A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42416202P 2002-11-06 2002-11-06

Publications (1)

Publication Number Publication Date
AR041885A1 true AR041885A1 (es) 2005-06-01

Family

ID=32312762

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104038A AR041885A1 (es) 2002-11-06 2003-11-04 Compuesto de sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion

Country Status (4)

Country Link
AR (1) AR041885A1 (es)
AU (2) AU2003291264A1 (es)
TW (1) TW200418831A (es)
WO (2) WO2004043463A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004275488A1 (en) 2003-09-26 2005-04-07 Actelion Pharmaceuticals Ltd Pyridine derivatives and use thereof as urotensin II antagonists
CN101039930B (zh) 2004-10-12 2010-08-11 埃科特莱茵药品有限公司 作为结晶硫酸盐的1-[2-(4-甲苯基-4-羟基-哌啶-1-基)-乙基]-3-(2-甲基-喹啉-4-基)-脲
CL2007002097A1 (es) 2006-07-20 2008-01-18 Smithkline Beecham Corp Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras.
EP2590957B1 (en) 2010-07-09 2014-11-12 Pfizer Limited N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3378565A (en) * 1966-04-25 1968-04-16 Dow Chemical Co Sulfamoylpyridyl phosphorothioates and intermediates therefor
US5338739A (en) * 1994-03-10 1994-08-16 Hoechst-Roussel Pharmaceuticals Inc. (Pyrrolidinyl)phenyl carbamates, compositions and use
US5869428A (en) * 1995-03-13 1999-02-09 Ishihara Sangyo Kaisha Ltd. Pyridonesulfonylurea compounds, process for their production and herbicides containing them

Also Published As

Publication number Publication date
AU2003291264A1 (en) 2004-06-03
AU2003287529A1 (en) 2004-06-03
WO2004043463A3 (en) 2004-06-17
WO2004043463A2 (en) 2004-05-27
WO2004043948A1 (en) 2004-05-27
TW200418831A (en) 2004-10-01

Similar Documents

Publication Publication Date Title
PE20140630A1 (es) Derivados de acido 3-fenilpropionico ramificados y su uso
CL2008001205A1 (es) Compuestos derivados de biciclo[2.2.2]octeno; composicion farmaceutica que los contiene; y uso en el tratamiento o prevencion de angina cronica estable, hipertension, isquemia renal y cardiaca, arritmias cardiacas, hipertrofia cardiaca y falla congestiva del corazon.
AR109958A1 (es) Lactamas bicíclicas de piridona y sus métodos de uso
NO20043380L (no) Farmasoytiske sammensetninger som innbefatter valsartan og NEP-inhibitorer
AR042109A1 (es) Derivados de acido mandelico, procedimiento de preparacion, composicion farmaceutica que lo comprende, y, usos
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
AR068054A1 (es) Compuestos de pirrolopirimidina
AR071385A1 (es) Compuestos de 2-imino-3-metil pirrolopirimidinona sustituida con tiofenilo,composiciones farmaceuticas que los contienen,y uso de los mismos para el tratamiento de patologias asociadas con la proteina beta amiloide,tales como alzheimer y otros formas de demencia.
EA200300453A1 (ru) Производные 3-ароилиндола и их применение в качестве агонистов рецепторов cb2
CO5611139A2 (es) Pirimidinas aril sustituidas y el uso de las mismas
CO5640098A2 (es) Acidos biariloximetilaren-carboxilicos
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
PE20130683A1 (es) Ariltriazolonas ligadas a bisarilo y su uso
PE20061451A1 (es) Compuestos derivados de diarilsulfona sulfonamidas
AR048213A1 (es) 1-(4-mono-y di-halometilsulfonilfenil)-2-acilamino-fluorpropanoles analogos al florfenicol
AR073031A1 (es) Composiciones terapeuticas que contienen macitentan
EA200200912A1 (ru) Новые производные индолин-2-она, их получение и их применение в качестве лигандов рецепторов окситоцина
CL2007002097A1 (es) Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras.
AR031226A1 (es) 1,1'-bifenil-2-carboxamidas 2'-sustituidas, procesos para su preparacion, su uso para la manufactura de un medicamento, y composiciones farmaceuticas que las contienen
AR074353A1 (es) Acidos naftalen-2-il-aceticos sustituidos, composiciones farmaceuticas que los contienen, y uso de los mismos en el tratamiento de enfermedades alergicas,tales como rinitis, asma y dermatititis atopica.
EA200500420A1 (ru) Бензолсульфонатные соли производных 4-фтор-2-цианопирролидина
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
CO5680413A2 (es) Aminoacidos con afinidad por la proteina c2 delta
AR041855A1 (es) 4 amino-1- (piridilmetil) piperidina sustituida y compuestos relacionados
AR041885A1 (es) Compuesto de sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion

Legal Events

Date Code Title Description
FB Suspension of granting procedure